Dec 21 2018

Cyclica drives new research capabilities for Merck KGaA, Darmstadt, Germany, through its AI Augmented Screening Platform

TORONTO — December 20, 2018 Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced that it has entered into a licensing agreement with Cyclica Inc. for the use of Ligand Express®, a cloud-based in silico proteome screening platform. Ligand Express® is a structure-based and artificial intelligence (AI) augmented proteome screening platform that is […]

Nov 27 2018

Cyclica Drives Drug Discovery Through AI-Augmented Integrated Network of Cloud-Based Technologies together with Bayer

TORONTO — November 26, 2018 Cyclica (, a Bayer G4A company is pleased to announce a collaboration with Bayer to advance drug discovery programs by gaining insights into the polypharmacological profiles of small molecules, while further evolving Cyclica’s integrated network of enabling technologies. Through a multi-phase collaboration, Cyclica will provide its cloud-based proteome screening Ligand […]

Sep 27 2018

Nanovista Appoints Dr. Vincent Lenaerts As New CEO

Toronto, ON – September 27, 2018 GreenSky Capital Inc. is very pleased to welcome Dr. Vincent Lenaerts as the new Chief Executive Officer of Nanovista Inc. (“Nanovista”). Dr. Lenaerts has executive experience in a variety of fields including nanotechnologies, drug delivery, diagnostics, peptides, endocrinology, ophthalmology and oncology and has held CEO positions at Miraculins, Bioxalis […]

Sep 06 2018

GreenSky Accelerator Funds Invest in Weever Apps

Toronto, ON – September 6, 2018 GreenSky Capital Inc. is pleased to announce that its affiliated venture funds, the GreenSky Accelerator Funds I and II, have led a $900K equity investment in Weever Apps in syndicate with members of the GreenSky President’s Club. Weever is a Hamilton-based software company that makes technology to simplify processes […]

Jul 12 2018

AOMS Technologies Announces the Launch of LumiCon™, a New Generation of Concrete Sensors

This article was published on PRNewswire Toronto – July 11, 2018 AOMS Technologies Inc. ( announced the launch of LumiCon™, an in-situ distributed concrete monitoring platform using AOMS patented Fiber Optic Sensing Technology (AOMS-FOS™). AOMS LumiCon™ system enables general contractors and ready-mix concrete producers to remotely collect continuous, distributed, and real-time temperature and moisture data […]

Pyrowave Receives First Investment of Export Development Canada’s new Cleantech Co-Investment Program

Toronto – July 9, 2018 GreenSky Capital is proud to announce that Pyrowave Inc.. which uses its unique microwave technology to process plastic waste, will receive a $1-million investment under Export Development Canada’s (EDC) new Cleantech Co-Investment Program. It is the first investment of the program. Said Pyrowave CEO Jocelyn Doucet, “We’re proud to be […]

Apr 03 2018

GreenSky Accelerator Fund II Invests in ProNavigator

Update: GreenSky President’s Club – Further Investment in ProNavigator Toronto, ON – March 27, 2018 GreenSky Capital Inc. is pleased to announce that members of the GreenSky President’s Club have made a $350,000 investment as part of a seed round in ProNavigator Technologies Ltd. (“ProNavigator”). In addition to the original $400,000 lead investment made by […]

Feb 21 2018

The Top Barrier To AI In Drug Discovery May Surprise You

Source – By Simon Smith He nailed the presentation. It was March 2016. Naheed Kurji was pitching his AI drug discovery startup, Cyclica. The audience was a large group of scientists. It included senior scientists and heads of computational drug discovery and chemistry. These were the right people. Kurji hit the key points and […]

Feb 12 2018

GreenSky Accelerator Funds Invest in Nanovista

Toronto, ON – February 12th, 2018 GreenSky Capital Inc. is pleased to announce that its affiliated venture funds, the GreenSky Accelerator Fund I and GreenSky Accelerator Fund II, have made a $750,000 lead investment as part of a $2.3M seed round investment in Nanovista Inc. (“Nanovista“). Nanovista develops multimodal visualization agents designed to improve the […]

Dec 06 2017

Cyclica Launches Ligand Express™, a Disruptive Cloud-Based Platform to Revolutionize Drug Discovery

TORONTO – November 30, 2017 GreenSky Capital client Cyclica is launching its novel cloud-based, proteome screening platform, Ligand Express™. The unique platform, which harnesses biophysics, biological data, and artificial intelligence (AI), is actively being used by pharmaceutical scientists to more efficiently navigate the drug discovery pipeline. The web-accessible platform ( grants users access to Cyclica’s […]